Effect of passive immunization with antisera to vasoactive intestinal polypeptide and peptide histidine isoleucine amide on 5-hydroxy-L-tryptophan-induced prolactin release in rats.

作者: HIDESUKE KAJI , KAZUO CHIHARA , HIROMI ABE , TETSUYA KITA , YOICHI KASHIO

DOI: 10.1210/ENDO-117-5-1914

关键词: StimulationDopaminergicInternal medicineChemistryVasoactive intestinal peptidePeptide PHIProlactinEndogenySerotoninEndocrinologySulpiride

摘要: The present study was aimed to clarify, by use of the passive immunization method, involvement endogenous vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine amide (PHI)-like peptides in stimulation PRL-like immunoreactive material release induced 5-hydroxy-L-tryptophan (5HTP), a serotonin precursor. We used conscious, freely moving male rats Wistar strain (BW, 250-300 g) chronically cannulated with atrial catheters. Anti-VIP serum (AVS) anti-PHI (APS), each generated rabbits against synthetic porcine VIP natural PHI, respectively, were highly potent [maximum binding capacity (Bmax): AVS, 55.5 nmol/ml; APS, 5.53 nmol/ml] specific. Bolus injection 5HTP (10 mg/kg BW) through catheter caused significant increase plasma PRL (nanograms per ml) pretreated normal rabbit (NRS) [14.3 +/- (SE) 3.8----56.3 11.2], AVS (12.3 3.5----48.5 6.2), APS (10.5 3.9----43.5 8.8), plus (9.0 1.4----28.5 2.7). basal concentrations did not differ significantly among these groups, whereas responses blunted APS-pretreated (P less than 0.05 vs. NRS). To eliminate modification dopaminergic control 5HTP-induced release, next experiment performed repeatedly injected sulpiride, dopamine receptor antagonist (5 BW), every 30 min. first sulpiride prompt marked PRL, followed decreasing but still high levels upon subsequent injections cumulative area after pretreatment or alone lower that NRS 0.05). same dose resulted further exceeding elevated NRS-treated rats. Prior simultaneous administration complete suppression either showed only minimal effect. These results suggest PHI-like are PRL-releasing factors, involved at least mechanism which may be also involved.

参考文章(26)
Akira Shimatsu, Yuzuru Kato, Tatsuhide Inoue, Nicos D. Christofides, Stephen R. Bloom, Hiroo Imura, Peptide histidine isoleucine- and vasoactive intestinal polypeptide-like immunoreactivity coexist in rat hypophysial portal blood Neuroscience Letters. ,vol. 43, pp. 259- 262 ,(1983) , 10.1016/0304-3940(83)90198-2
Kazuhiko Tatemoto, Mats Carlquist, Thomas J. McDonald, Viktor Mutt, Isolation of a brain peptide identical to the intestinal PHI (peptide HI) FEBS Letters. ,vol. 153, pp. 248- 252 ,(1983) , 10.1016/0014-5793(83)80617-6
J. SZECOWKA, P. E. LINS, K. TATEMOTO, S. EFENDIC, Effects of Porcine Intestinal Heptacosapeptide and Vasoactive Intestinal Polypeptide on Insulin and Glucagon Secretion in Rats Endocrinology. ,vol. 112, pp. 1469- 1473 ,(1983) , 10.1210/ENDO-112-4-1469
Y. F. CHEN, V. D. RAMIREZ, Serotonin Stimulates Thyrotropin-Releasing Hormone Release from Superfused Rat Hypothalami Endocrinology. ,vol. 108, pp. 2359- 2366 ,(1981) , 10.1210/ENDO-108-6-2359
ND Christofides, Y Yiangou, MA Blank, K Tatemoto, JM Polak, SR Bloom, Are peptide histidine isoleucine and vasoactive intestinal peptide co-synthesised in the same pro-hormone? The Lancet. ,vol. 320, pp. 1398- 1398 ,(1982) , 10.1016/S0140-6736(82)91292-2
George Scatchard, The Attractions of Proteins for Small Molecules and Ions Annals of the New York Academy of Sciences. ,vol. 51, pp. 660- 672 ,(1949) , 10.1111/J.1749-6632.1949.TB27297.X
Hidesuke Kaji, Kazuo Chihara, Hiromi Abe, Naoto Minamitani, Hitoshi Kodama, Tetsuya Kita, Takuo Fujita, Kazuhiko Tatemoto, Stimulatory effect of peptide histidine isoleucine amide 1–27 on proclactin release in the rat Life Sciences. ,vol. 35, pp. 641- 647 ,(1984) , 10.1016/0024-3205(84)90259-5